Sloan Sheldon

Insider

Chief Medical Officer

Trades at: SYRE

30D 90D 1Y

Net shares · 365d

-94.6K

0 buy · 94.6K sell

Net value · 365d

-$6.6M

$0 in · $6.6M out

Sentiment · 365d

Net selling

0% buying · 100% selling

Open-market trades · 365d

0 buy · 94.6K sell

Trading track record · all companies

Running net of open-market buys − sells across every company. Tap the line or a marker for details. ▲ buy · ▼ sell.

Transactions · 365d

Open-market Buys Sells All types

SYRE Sell·S
Jun 3, 26

Chief Medical Officer · 10b5-1

$625.0K

8.3K sh · $75.00

Own -100%
SYRE Sell·S
May 1, 26

Chief Medical Officer · 10b5-1

$5.6M

78.3K sh · $71.50 avg · 7 lots

Own -100%
SYRE Sell·S
Apr 1, 26

Chief Medical Officer · 10b5-1

$397.9K

8.0K sh · $50.00

Own -100%

Date▾	Ticker	Role	Type	Shares	Own Δ	Price	Value
Jun 3, 2026	SYRE	Chief Medical Officer	Sell S	8.3K	-100%	$75.00	$625.0K
May 1, 2026	SYRE	Chief Medical Officer	Sell S	78.3K7 lots	-100%	$71.50 avg	$5.6M
Apr 1, 2026	SYRE	Chief Medical Officer	Sell S	8.0K	-100%	$50.00	$397.9K

Buy Sell Non-market (grant · exercise · gift)

About Sloan Sheldon

This profile aggregates every SEC Form 4 insider transaction reported by Sloan Sheldon across all companies they trade. Open-market purchases (code P) and sales (code S) are the highest-signal, discretionary trades; grants (A), option exercises (M) and gifts (G) reflect compensation rather than conviction and carry no market price. Figures cover the selected period and update as new filings are ingested.